Heartbeat Health, a healthcare company working to deliver the most effective, efficient, and engaging heart care, announced today that it has raised $20 million in Series B funding, led by Echo Health Ventures, with participation from DaVita Venture Group and existing investors, .406 Ventures, Optum Ventures, Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures.
Heartbeat Health was founded with a mission to fundamentally reshape cardiovascular care to better address heart disease, the costliest and deadliest disease globally. Heartbeat delivers virtual-first cardiovascular disease prevention and management with a focus on improved clinical experience, health outcomes, and reduced costs. The Heartbeat virtual-first platform offers a best-in-class, data-powered patient and provider experience, combining telemedicine, diagnostic coordination, medication management, lifestyle guidance, and stakeholder engagement.
“We’ve built a remarkable virtual-first platform to standardize and scale cardiovascular care for patients who need it the most. By working with at-risk organizations our model has focused on improving clinical outcomes at lower costs and provides a much-needed data-driven approach to this growing field of virtual care,” says Dr. Jeff Wessler, a cardiologist and the company’s co-founder and CEO.
The $20 million Series B investment will be used to accelerate product research and development as well as expand clinical services offered to at-risk organizations. Heartbeat has delivered care to more than 20,000 patients nationwide.
“From the beginning, Heartbeat focused on evidence-based care, patient outcomes, cost-effectiveness, and clinical tools for cardiologists built by cardiologists. With this focus, they have already emerged as a market leader in a new model of patient-focused care for heart health,” says Jessica Zeaske, a Partner at Echo Health Ventures who will join the Board of Directors at Heartbeat. “Echo Health Ventures looks forward to partnering with Heartbeat Health to address the critical issues of cardiovascular disease prevention and management through Heartbeat’s platform and new model of value-based care.”
Despite tremendous advancements in cardiovascular diagnostics and therapies, nearly 40% of the US population has heart disease. Heartbeat is working to change that statistic by decoupling heart care from physical locations and transient moments in time. “We make it possible to superpower cardiologists with digital tools and workflows that break care out of the clinic in both location and time,” says Mark Hanson, Heartbeat’s co-founder and Chief Product Officer. This approach has been embraced by the American College of Cardiology, a Heartbeat strategic partner.
Heartbeat is now focused on scaling virtual, value-based cardiovascular care to at risk groups. This requires a hybrid approach to care that relies on providers and technology. “The platform and services work together seamlessly by using data to uncover guidance that can not only treat individuals at-risk, but to help entire populations living with heart disease – and that is a big idea worth pursuing,” says Nayan Jain, a co-founder and the company’s CTO.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.
